← Open Payments lookup

KRITHIKA MULLENGADA: Open Payments

NPI 1992785562 · SUCCASUNNA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$202 in 11 payments from 8 companies in 2025. Trend: 2023 $242 · 2024 $239 · 2025 $202

Food & beverage: $202
CompanyPaymentsAmount
GlaxoSmithKline, LLC.3$54
Novo Nordisk Inc2$33
Exact Sciences Corporation1$32
Bausch Health US, LLC1$19
Sumitomo Pharma America, Inc.1$18
Xeris Pharmaceuticals, Inc.1$18
Lilly USA, LLC1$15
Esperion Therapeutics, Inc.1$14

Products named: SHINGRIX, Cologuard Collection Kit, WELLBUTRIN, TRELEGY ELLIPTA, Ozempic, GEMTESA, RECORLEV, MOUNJARO.

Industry payments across NJ — which companies pay providers there.